Migraine management: an update for the 2020s

Eller, Michael; Cheng, Sheue-yann

doi:10.1111/imj.15843

Cited by 4 publications

(3 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Defining morphological anatomical substrate is the main step in defining an illness or disorder but in this case, we must evaluate that the systems and their interaction understanding presents the main step in definition of functional GI disorders and migraine attacks [30].…”

Section: Discussionmentioning

confidence: 99%

Is there a difference between patients with functional dyspepsia and irritable bowel syndrome in headache manifestation?

et al. 2023

View full text Add to dashboard Cite

Introduction/Objective. The objective was to explore whether there is a difference in headache manifestation and level of its intensity in patients with functional dyspepsia and irritable bowel syndrome. Methods. We assessed a cohort of N=420 participants out of which N=300 satisfied presence of irritable bowel syndrome (148) or functional dyspepsia (152) as a recruiting criterion. Diagnoses of irritable bowel syndrome and functional dyspepsia were made according to Rome IV criteria. Intensity of headaches was estimated in irritable bowel syndrome and functional dyspepsia participants using visual-analog scale. All patients underwent subsequent testing by Hamilton's depression inventory and anxiety scale. Results. Our results showed that males with headaches are more susceptible to functional dyspepsia, statistical significance in the group of patients with irritable bowel syndrome with high scores visual analog scales, in relation of Hamilton?s anxiety scores in the group of patients with irritable bowel syndrome. Gender and visual analogue scale scores were determinants to show whether the patient falls within the group of functional dyspepsia or irritable bowel syndrome. Scores of visual analogue scale where the patient felt the best was statistically borderline (p = 0.061) and its higher values pinpointed which of those patients fall into irritable bowel syndrome group. Conclusion. Gender and level of headache intensity as a extraintestinal manifestation showed to be the main variables to make a difference between patients with functional dyspepsia and irritable bowel syndrome where irritable bowel syndrome had higher scores and greater dominance in differential diagnosis if the headache was determining variable.

show abstract

Section: Discussionmentioning

confidence: 99%

Is there a difference between patients with functional dyspepsia and irritable bowel syndrome in headache manifestation?

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In this issue, Eller and Cheng describe the current state of migraine therapeutics, with a particular emphasis on the current CGRP inhibitors currently in use 18 . In monoclonal antibody form, there is erenumab, fremanezumab, galcanezumab and eptinezumab.…”

mentioning

confidence: 99%

“…In this issue, Eller and Cheng describe the current state of migraine therapeutics, with a particular emphasis on the current CGRP inhibitors currently in use. 18 In monoclonal antibody form, there is erenumab, fremanezumab, galcanezumab and eptinezumab. The authors outline how and when to use specific therapies and how these therapies may improve the lives of our patients who suffer debilitating chronic migraine.…”

mentioning

confidence: 99%